Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
COGNITION THERAPEUTICS, INC.
About CGTX
Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of small molecule therapeutics targeting age-related degenerative disorders of the central nervous system and retina. The Company is investigating its lead candidate, zervimesine (CT1812), in clinical programs in dementia with Lewy bodies (DLB) and Alzheimer’s disease. Its CT1812 and pipeline of sigma-2 modulators can regulate pathways that are impaired in these diseases for the treatment of degenerative diseases. Its lead product candidate, CT1812, is an orally delivered, small molecule designed to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins. Its pipeline candidates were discovered using proprietary biology and chemistry platforms designed to identify novel drug targets and disease-modifying therapies that address dysregulated pathways. It is developing other product candidates in the area of synucleinopathies.
Find out what a historical investment in COGNITION THERAPEUTICS, INC. would be worth today using our CGTX stock calculator.
Market Capitalisation
$102.03M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
765.65K
High today
$1.20
Low today
$1.11
Open price
$1.20
52-week high
$3.83
52-week low
$0.22
Ready to start your investing journey with Stake?
Open an accountHow do I buy CGTX shares in Australia?
Buying CGTX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in COGNITION THERAPEUTICS, INC. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CGTX
What is the ticker symbol of COGNITION THERAPEUTICS, INC.?
The ticker symbol for COGNITION THERAPEUTICS, INC. is CGTX.
How much is one share of CGTX?
One share of CGTX is valued at $1.15 as of 17 May 2026.
What is the market capitalisation of COGNITION THERAPEUTICS, INC. CGTX?
As of 17 May 2026 COGNITION THERAPEUTICS, INC. has a market cap of $102.03M.
What is the 52-week high for COGNITION THERAPEUTICS, INC. stock?
The COGNITION THERAPEUTICS, INC. 52-week high stock price is $3.83.
What is the 52-week low for COGNITION THERAPEUTICS, INC. stock?
The COGNITION THERAPEUTICS, INC. 52-week low stock price is $0.22.
Can I buy CGTX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CGTX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CGTX on Stake
- Buy CGTX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of CGTX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
CGTX related stocks